Euclidean Capital as of Sept. 30, 2021
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 10 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pmv Pharmaceuticals (PMVP) | 40.1 | $83M | 2.8M | 29.80 | |
| Alector (ALEC) | 10.9 | $22M | 981k | 22.82 | |
| Rapt Therapeutics (RAPT) | 9.6 | $20M | 635k | 31.05 | |
| Tenaya Therapeutics (TNYA) | 9.2 | $19M | 916k | 20.65 | |
| Foghorn Therapeutics (FHTX) | 8.5 | $18M | 1.3M | 13.93 | |
| Ngm Biopharmaceuticals (NGM) | 8.5 | $18M | 832k | 21.02 | |
| Oric Pharmaceuticals (ORIC) | 7.9 | $16M | 777k | 20.91 | |
| Surrozen | 2.8 | $5.7M | 803k | 7.08 | |
| First Financial Ban (FFBC) | 2.0 | $4.1M | 174k | 23.41 | |
| Pinduoduo Sponsored Ads (PDD) | 0.5 | $1.1M | 12k | 90.69 |
